STOCK TITAN

I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
I-Mab (IMAB) to present at the 23rd Annual Needham Virtual Healthcare Conference on April 11, 2024, focusing on immunotherapies for cancer treatment. The presentation will feature key executives and offer opportunities for one-on-one meetings.
Positive
  • None.
Negative
  • None.

ROCKVILLE, Md., April 5, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB), a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer, today announced that management will present at the 23rd Annual Needham Virtual Healthcare Conference on April 11, 2024.

23rd Annual Needham Virtual Healthcare Conference

Presentation Time

Thursday, April 11 at 10:15 a.m. EST

Presenters

Raj Kannan, CEO; John Hayslip CMO

Webcast link

Here

Meetings

One-on-one and small group meetings: April 11, 2024

Management
Participants

Raj Kannan, CEO

Joe Skelton, CFO

John Hayslip, CMO
Tyler Ehler, Senior Director, Investor Relations

The webcast will also be available under "Event Calendar" on I-Mab's IR website
at http://ir.i-mabbiopharma.com/

For more information, please contact your Needham representative.

About I-Mab

I-Mab (NASDAQ: IMAB) is a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer. I-Mab has established operations in Rockville, Maryland, and in San Diego, California. For more information, please visit http://www.i-mabbiopharma.com and follow us on LinkedIn and X.

For more information, please contact:
Tyler Ehler
Senior Director, Investor Relations
IR@imabbio.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/i-mab-to-participate-at-the-23rd-annual-needham-virtual-healthcare-conference-302108935.html

SOURCE I-Mab Biopharma

FAQ

When is I-Mab (IMAB) presenting at the 23rd Annual Needham Virtual Healthcare Conference?

I-Mab (IMAB) will present on April 11, 2024, at 10:15 a.m. EST.

Who are the key executives presenting at the conference from I-Mab (IMAB)?

The key executives presenting are Raj Kannan, CEO, and John Hayslip, CMO.

Where can I watch the webcast of I-Mab's (IMAB) presentation at the conference?

The webcast will be available on I-Mab's IR website at http://ir.i-mabbiopharma.com/ under 'Event Calendar'.

Are there opportunities for one-on-one meetings with I-Mab's (IMAB) management at the conference?

Yes, there will be one-on-one and small group meetings with management on April 11, 2024.

How can I get more information about I-Mab's (IMAB) participation in the conference?

For more information, you can contact your Needham representative.

I-MAB American Depositary Shares

NASDAQ:IMAB

IMAB Rankings

IMAB Latest News

IMAB Stock Data

76.29M
62.31M
11.16%
30.88%
0.76%
Biotechnology
Healthcare
Link
United States of America
Rockville